Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$2.26 - $3.27 $112,999 - $163,500
-50,000 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$3.02 - $4.94 $90,600 - $148,200
-30,000 Reduced 37.5%
50,000 $151,000
Q1 2018

May 15, 2018

BUY
$3.46 - $5.14 $276,800 - $411,200
80,000 New
80,000 $314,000
Q4 2017

Feb 14, 2018

SELL
$4.0 - $6.54 $4,000 - $6,540
-1,000 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$4.99 - $6.57 $4,990 - $6,570
1,000
1,000 $6,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.